The effect of vitamin e treatment   
    
        
            .png)  
             | 
         
        
            
            วิตามินอี (Natural vitamin E (Alpha-tocopherol ))
            The effect of vitamin e treatment on tardive dyskinesia and blood superoxide dismutase: a double-blind placebo-controlled trial.
            
            Zhang XY, Zhou DF, Cao LY, Xu CQ, Chen da C, Wu GY. 
                                      
            Institute of Mental Health, Peking University, 100083 Beijing, China;  dagger Beijing Hui-Long-Guan Hospital, 100096 Beijing, China. 
                                      
            SUMMARY: Free radicals may be involved in the pathogenesis of tardive  dyskinesia (TD). Vitamin E, a free radical scavenger, has been reported  to improve symptoms of TD. The present study was designed to replicate  this finding in a group of Chinese patients with TD, and to examine the  effect of vitamin E treatment on blood superoxide dismutase (SOD), a  critical enzyme in the detoxification of free radicals. Forty-one  inpatients with TD completed a double-blind, placebo-controlled,  parallel-group study of vitamin E. Twenty-two of the patients were  randomly assigned to receive a fixed dose of 1200 IU/d vitamin E, and 19  were assigned to a placebo for 12 weeks. Patients were assessed  primarily using the Abnormal Involuntary Movement Scale (AIMS) at  baseline, weeks 6 and 12. Blood SOD levels were measured by  radioimmunometric assay before and after treatment. The results showed  that the reduction in AIMS score from baseline was significantly higher  with vitamin E treatment compared with placebo (45.9% vs. 4.3%). Blood  SOD levels were significantly increased after treatment with vitamin E  (P = 0.001), but no change with placebo treatment (P < 0.05). These  results support earlier findings of the efficacy of vitamin E in the  treatment of TD. Moreover, the efficacy of vitamin E may be due to its  ability to increase SOD level, which may reduce oxidative injure in  tardive dyskinesia. 
             
            PMID: 14709952 [PubMed - in process] 
             | 
         
    
 
   |